Barbara A. Chatfield

2.5k total citations
25 papers, 1.7k citations indexed

About

Barbara A. Chatfield is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Barbara A. Chatfield has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Barbara A. Chatfield's work include Cystic Fibrosis Research Advances (13 papers), Neonatal Respiratory Health Research (11 papers) and Pneumonia and Respiratory Infections (5 papers). Barbara A. Chatfield is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Neonatal Respiratory Health Research (11 papers) and Pneumonia and Respiratory Infections (5 papers). Barbara A. Chatfield collaborates with scholars based in United States, Italy and United Kingdom. Barbara A. Chatfield's co-authors include Steven H. Abman, Ivan F. McMurtry, David N. Cornfield, Jan M. Kennaugh, Adam A. Rosenberg, Steve Abman, Stacia L. Koppenhafer, Michael S. Schaffer, David M. Rodman and Steven H. Abman and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, PEDIATRICS and The Journal of Pediatrics.

In The Last Decade

Barbara A. Chatfield

25 papers receiving 1.6k citations

Peers

Barbara A. Chatfield
Serge Motte Belgium
R Leung Hong Kong
WK Lam Hong Kong
T W Higenbottam United Kingdom
Josef Hoegel Germany
Harry S. Dweck United States
L. Engelmann Germany
Serge Motte Belgium
Barbara A. Chatfield
Citations per year, relative to Barbara A. Chatfield Barbara A. Chatfield (= 1×) peers Serge Motte

Countries citing papers authored by Barbara A. Chatfield

Since Specialization
Citations

This map shows the geographic impact of Barbara A. Chatfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Chatfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Chatfield more than expected).

Fields of papers citing papers by Barbara A. Chatfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Chatfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Chatfield. The network helps show where Barbara A. Chatfield may publish in the future.

Co-authorship network of co-authors of Barbara A. Chatfield

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Chatfield. A scholar is included among the top collaborators of Barbara A. Chatfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Chatfield. Barbara A. Chatfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDonald, Catherine M., et al.. (2015). Vitamin D Deficiency in Pediatric Patients with Cystic Fibrosis: Associated Risk Factors in the Northern United States. Southern Medical Journal. 108(3). 164–169. 8 indexed citations
2.
Conrad, C., James Lymp, Valeria Thompson, et al.. (2014). Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. Journal of Cystic Fibrosis. 14(2). 219–227. 80 indexed citations
3.
Rock, Michael J., et al.. (2013). 38 Sweat testing using the CF Quantum® Sweat Test system. Journal of Cystic Fibrosis. 12. S58–S58. 1 indexed citations
4.
Zobell, Jeffery T., David C. Young, C. Dustin Waters, et al.. (2011). A survey of the utilization of anti‐pseudomonal beta‐lactam therapy in cystic fibrosis patients. Pediatric Pulmonology. 46(10). 987–990. 38 indexed citations
5.
Borowitz, Drucy, Christopher Stevens, Lee Brettman, et al.. (2011). International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. Journal of Cystic Fibrosis. 10(6). 443–452. 25 indexed citations
6.
Zobell, Jeffery T., Chris Stockmann, David C. Young, et al.. (2011). Population Pharmacokinetic and Pharmacodynamic Modeling of High-Dose Intermittent Ticarcillin-Clavulanate Administration in Pediatric Cystic Fibrosis Patients. Clinical Therapeutics. 33(11). 1844–1850. 10 indexed citations
7.
Pohl, John F., Raza Patel, Jeffery T. Zobell, et al.. (2011). Clostridium difficileInfection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients. Gastroenterology Research and Practice. 2011. 1–4. 15 indexed citations
8.
Treggiari, Miriam M., George Retsch‐Bogart, Nicole Mayer-Hamblett, et al.. (2011). Comparative Efficacy and Safety of 4 Randomized Regimens to Treat EarlyPseudomonas aeruginosaInfection in Children With Cystic Fibrosis. Archives of Pediatrics and Adolescent Medicine. 165(9). 847–847. 163 indexed citations
9.
Uchida, Derek A., et al.. (2011). Pulmonary Nodules in a Newborn With ATP-Binding Cassette Transporter A3(ABCA3)Mutations. PEDIATRICS. 127(5). e1347–e1351. 4 indexed citations
10.
Pohl, John F., et al.. (2011). Cystic Fibrosis and Celiac Disease. Clinical Pediatrics. 50(12). 1153–1155. 5 indexed citations
11.
Zobell, Jeffery T., Krow Ampofo, Jared Cash, Kent Korgenski, & Barbara A. Chatfield. (2010). High dose intermittent ticarcillin–clavulanate administration in pediatric cystic fibrosis patients. Journal of Cystic Fibrosis. 9(4). 280–283. 9 indexed citations
12.
Lowichik, Amy, et al.. (2010). Cystic Fibrosis and Celiac Disease: Both Can Occur Together. Clinical Pediatrics. 50(12). 9 indexed citations
13.
Wooldridge, Jamie L., James E. Heubi, Steven R. Boas, et al.. (2009). EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. Journal of Cystic Fibrosis. 8(6). 405–417. 49 indexed citations
14.
Gibson, Ronald L., Julia Emerson, Nicole Mayer‐Hamblett, et al.. (2007). Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatric Pulmonology. 42(7). 610–623. 78 indexed citations
15.
Fan, Leland L., et al.. (1997). Diagnostic value of transbronchial, thoracoscopic, and open lung biopsy in immunocompetent children with chronic interstitial lung disease. The Journal of Pediatrics. 131(4). 565–569. 62 indexed citations
16.
Rosenberg, Adam A., et al.. (1993). Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. The Journal of Pediatrics. 123(1). 109–114. 155 indexed citations
17.
Allen, S. W., et al.. (1993). Circulating Immunoreactive Endothelin-1 in Children with Pulmonary Hypertension: Association with Acute Hypoxic Pulmonary Vasoreactivity. American Review of Respiratory Disease. 148(2). 519–522. 128 indexed citations
18.
Sokol, Ronald J., Steven H. Abman, Barbara A. Chatfield, et al.. (1992). Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. The Journal of Pediatrics. 120(4). 533–540. 121 indexed citations
19.
Cornfield, David N., et al.. (1992). Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. American Journal of Physiology-Heart and Circulatory Physiology. 262(5). H1474–H1481. 172 indexed citations
20.
Abman, Steven H., et al.. (1990). Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. American Journal of Physiology-Heart and Circulatory Physiology. 259(6). H1921–H1927. 345 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026